Physician profile
Joseph R Aragon
NPI 1023122587
$286,961.84
in general payments reported to CMS, 2019-2025
33 companies · $37K in 2025
The $37K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $45K · 2021: $19K · 2022: $26K · 2023: $67K · 2024: $41K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Food and Beverage: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $9,425 · Grant: $2,975 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,125 · Education: $9.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,540.00 |
| Food and Beverage | $27,398.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,125.00 |
| Travel and Lodging | $9,425.42 |
| Grant | $2,975.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,125.00 |
| Education | $9.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $92,050.99 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Product In Development |
| Boston Scientific Corporation | $73,560.55 | 2019-2025 | Versacross Access Solution, Watchman Access System, Versacross Large Access Solution |
| Edwards Lifesciences Corporation | $59,404.07 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $15,670.00 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $14,572.53 | 2019-2025 | Pressurewire, Dragonfly Opstar, Triclip |
| Medtronic Vascular, INC. | $10,202.34 | 2019-2020 | |
| Medtronic, INC. | $8,352.43 | 2021-2025 | Corevalve Evolut R, Micra, Symplicity G3 |
| Astrazeneca Pharmaceuticals Lp | $5,450.30 | 2019-2025 | Farxiga, Wainua |
| Chiesi USA, INC. | $2,470.65 | 2019-2023 | Kengreal, Cleviprex |
| Abiomed | $1,653.78 | 2020-2024 | Impella |
| Teleflex LLC | $429.92 | 2022-2023 | Manta |
| Amgen INC. | $328.37 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $302.20 | 2019-2025 | Invega Sustenna |
| Surmodics, INC. | $284.40 | 2025 | Pounce Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System |
| Inari Medical, INC. | $272.34 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $271.22 | 2021-2025 | Igt Devices Systems Undivided, (P84) Igt Devices Systems, (9148) Ice 3d |
| Siemens Medical Solutions USA, INC. | $265.08 | 2025 | Naeotom Alpha |
| Biosense Webster, INC. | $224.34 | 2023-2024 | Nuvision Ice Catheter |
| Regeneron Healthcare Solutions, INC. | $196.52 | 2019 | |
| Asahi Intecc USA, INC. | $146.16 | 2025 | Asahi Coronary Wires |
| Portola Pharmaceuticals, LLC | $139.75 | 2019 | |
| Elutia, INC. | $133.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $119.76 | 2019-2025 | |
| Imperative Care, INC | $115.95 | 2023 | Prodigy Catheter |
| Irhythm Technologies, INC. | $113.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $105.63 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $40.63 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.58 | 2019 | |
| Atricure, INC. | $16.17 | 2019 | |
| Pfizer INC. | $15.81 | 2019 | |
| Amarin Pharma, INC. | $15.50 | 2019 | |
| Acist Medical Systems, INC. | $14.72 | 2019 | |
| Cardiovascular Systems INC. | $4.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Aragon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.